Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|13|14|1692-1706

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.14, 2013-07, pp. : 1692-1706

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M.   Kazmi Y.   Jann M.W.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Coumarins: Auspicious Cholinesterase and Monoamine Oxidase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 17, 2015-09 ,pp. : 1673-1682

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J.   Morris J.C.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment

By  

Current Drug Targets, Vol. 13, Iss. 4, 2012-04 ,pp. : 483-494

Bentham Science Publishers

Access to resources Recommend Favorite